Steris (STE) Gets a Hold Rating from Needham
Needham analyst Michael Matson assigned a Hold rating to Steris (STE) today. The company’s shares closed last Tuesday at $192.71, close to its 52-week high of $203.91.
According to TipRanks.com, Matson is a 5-star analyst with an average return of 15.4% and a 68.8% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings.
The the analyst consensus on Steris is currently a Hold rating.
See today’s analyst top recommended stocks >>
Steris’ market cap is currently $17.1B and has a P/E ratio of 41.10. The company has a Price to Book ratio of 25.48.
Based on the recent corporate insider activity of 58 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of STE in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.